Centromere 17 copy number gain reflects chromosomal instability in breast cancer
Open Access
- 29 November 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-11
Abstract
Chromosomal instability (CIN) is known to be associated with prognosis and treatment response in breast cancer. This study was conducted to determine whether copy number gain of centromere 17 (CEP17) reflects CIN, and to evaluate the prognostic and predictive value of CIN in breast cancer. CIN status was determined by summing copy number gains of four centromeric probes (CEP1, CEP8, CEP11, and CEP16) based on fluorescence in situ hybridization and CIN scores were calculated using next generation sequencing data. High CIN was associated with adverse clinicopatholgical parameters of breast cancer. Among them, positive HER2 status, high Ki-67 index and CEP17 copy number gain were found to be independent predictors of high CIN. High CIN was associated with poor clinical outcome of the patients in the whole group, as well as in luminal/HER2-negative and HER2-positive subtypes. CEP17 copy number was significantly higher in the high-CIN-score group than in the low-CIN-score group. A positive linear correlation between the mean CEP17 copy number and the CIN score was found. In conclusion, CEP17 copy number was confirmed as a useful predictor for CIN in breast cancer, and high CIN was revealed as an indicator of poor prognosis in breast cancer.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2018R1A2B6005559)
This publication has 32 references indexed in Scilit:
- Prognostic significance of centromere 17 copy number gain in breast cancer depends on breast cancer subtypeHuman Pathology, 2017
- Chromosome 17 Centromere Duplication and Responsiveness to Anthracycline-Based Neoadjuvant Chemotherapy in Breast CancerNeoplasia, 2014
- Chromosome 17 polysomy: correlation with histological parameters and HER2NEU gene amplificationJournal of Clinical Pathology, 2013
- Multiplication of Chromosome 17 Centromere Is Associated with Prognosis in Patients with Invasive Breast Cancers Exhibiting NormalHER2andTOP2AStatusJournal of Breast Cancer, 2012
- Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A statusMolecular Oncology, 2011
- Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)The Lancet Oncology, 2010
- Poor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinomaLaboratory Investigation, 2009
- Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 TestingJournal of Clinical Oncology, 2008
- The effect of chromosome 17 polysomy on HER-2/neu status in breast cancerJournal of Clinical Pathology, 2007
- The Influence of Polysomy 17 on HER2 Gene and Protein Expression in Adenocarcinoma of the BreastAmerican Journal of Surgical Pathology, 2005